An accomplished team of
innovative leaders

Larry Jasinski has served as Chief Executive Officer and as a member of the Lifeward board since February 2012. From 2005 until 2012, Mr. Jasinski served as the President and Chief Executive Officer of Soteira, Inc., a company engaged in development and commercialization of products used to treat individuals with vertebral compression fractures, which was acquired by Globus Medical in 2012. From 2001 to 2005, Mr. Jasinski was President and Chief Executive Officer of Cortek, Inc., a company that developed next-generation treatments for degenerative disc disease, which was acquired by Alphatec in 2005. From 1985 until 2001, Mr. Jasinski served in multiple sales, research and development, and general management roles at Boston Scientific Corporation. Mr. Jasinski holds a B.Sc. in marketing from Providence College and an MBA from the University of Bridgeport.

Mike Lawless joined Lifeward as Chief Financial Officer in September 2022. Mr. Lawless brings more than 20 years of experience leading finance activities at life science and technology companies to drive greater financial discipline, better strategic decision making, and improved access to capital. Prior to joining Lifeward, Mr. Lawless served as a CFO consultant for Danforth Advisors, where he provided financial and analytical support services to early-stage life science companies. Among his previous roles, Mr. Lawless served as the CFO of Brooks Life Sciences, a $200 million division of Brooks Automation (now Azenta, Inc.) and Vice President, Financial Planning and Analysis for Brooks Automation and PerkinElmer, Inc. where he led all facets of planning, forecasting, and analysis activities. Mr. Lawless holds a Bachelor of Arts degree in Economics with a Concentration in Public Policy from Swarthmore College, and a Master of Business Administration degree from the Tuck School of Business at Dartmouth College, and he is a Certified Public Accountant.

Charles Remsberg joined Lifeward in 2023 in the newly created position of Chief Sales Officer, responsible for global sales of all Lifeward products. Prior to Lifeward, he served as CEO of AlterG, the manufacturer of the Anti-Gravity Treadmill. An industry veteran of over 30 years, Charles has been responsible for bringing innovative Rehabilitation Technology to Physical Therapy, Neuro-Rehabilitation, Sports Medicine, and Wellness customers. He has served in both executive, and commercial leadership roles for Tibion, Hocoma, and Biodex Medical Systems. He holds an AS in Business Administration from Suffolk County Community College.

Miri Pariente joined the company in April 2013 and serves as Vice President of Quality Assurance, Regulatory and Operation. From 2012 to 2013, Ms. Pariente was the Manager of Quality Assurance at NLT Spine Ltd., a developer of minimally invasive spine procedures, and, from 2011 to 2012, was the Manager of Quality Assurance at ProAccess Medical Ltd. From 2002 to 2010, Ms. Pariente served in multiple roles within American Medical Systems including Production Supervisor and Lean Leader. Ms. Pariente holds a B.A. in business management from Derby University.

Jeannine Lynch joined Lifeward in 2021, with a focus on completing the building and implementation of Lifeward’s market access and reimbursement programs.

Prior to Lifeward, Ms. Lynch served as Senior Director of Patient Access Services at BioMarin Pharmaceuticals. In addition to her work with BioMarin, Ms. Lynch has worked for industry leaders such as Genentech and Pfizer/Agouron. She has held leadership roles in commercial management, product launches and built customized patient services to address several different rare and ultrarare medical conditions.

Ms. Lynch is a graduate of the University of California Berkeley and holds a Master of Public Health from the University of Michigan. She sits on the Board of Directors for MVP, a non-profit organization to help young people of color prepare, perform, progress, and prosper in their education, leadership and early professional careers.

Kathleen O’Donnell joined Lifeward in 2018 and currently serves as Vice President of Marketing and New Business Development. Ms. O’Donnell received her Bachelor’s degree in Biomedical Engineering from Northwestern University, and her Master’s in Industrial Design from the Rhode Island School of Design.

Prior to joining Lifeward, Kathleen has held previous roles at Integra Lifesciences and most recently worked at the Wyss Institute for Biologically Inspired Engineering at Harvard University, where she combined her backgrounds in engineering and design to help lead the development and testing of exosuits, which later became the ReStore Exo-Suit with Lifeward. While at Lifeward, Ms. O’Donnell has held multiple roles in clinical trials and product management.

David Hexner joined Lifeward in November of 2011 and currently serves as Vice President of Research and Development. David has played an integral role in the development of both the ReWalk Exoskeleton and the ReStore Exo-suit, beginning first in the role of Software and Algorithms Engineer, then that of Program Manager and finally of Director of Research and Development prior to joining the management team in 2021.

Mr. Hexner received his Bachelor’s degree in Electrical Engineering, as well as his Masters of Business Administration from the Technion-Israel Institute of Technology. Prior to joining Lifeward, David previously worked at Zoran Electronics which used to be a leading player in the semiconductor market which developed and sold chip sets for consumer electronics.

Almog Adar joined the company in January 2020 and currently serves as Vice President of Finance. Almog served in several critical positions in the company’s finance department as a corporate controller and Director of Finance before joining the management team in 2022. Prior to joining Lifeward, Almog previously worked as Controller of Infinya Recycling Ltd (previously Amnir Recycling), from January 2018 until December 2019. From January 2016 until December 2017, Mr. Adar served as Assistant Controller of Delta Galil Industries. Mr. Adar has a Bachelor of Arts degree in Accounting and Economics from the Open University of Israel and is a Certified Public Accountant licensed by the Israeli Ministry of Justice.

Judy Kula joined the company in August 2012 and serves as the Vice President of Customer Service, Human Resources and Business Affairs. Ms. Kula started her career at the University of Massachusetts Medical School working for the Chairman of the Department of Biochemistry and Director of the Program in Molecular Medicine for 13 years and then worked for the Hospital Director at the University of Massachusetts Medical Center. Ms. Kula then served in a variety of start-up companies in biotech and computer software including Microbotix, Inc. and Red Tail Solutions, Inc. and over the last 10 years has served in the medical device field including Soteira, Inc. Ms. Kula holds an MBA with a minor in health care from Anna Maria College.

Ami Kraft joined the company in 2010. Mr. Kraft has been appointed as Executive Advisor to the CEO as of October 2017. Mr. Kraft previously served the company as President since August 2016, Senior Vice President from July 2015, and General Manager of ReWalk Robotics Ltd. in Israel since January 1, 2015. These positions are following his six-year tenure as our Chief Financial Officer, including the successful IPO in 2014. Before joining Lifeward, Mr. Kraft served as the Chief Financial Officer of various international technology companies, including PicScout, which was bought by Getty Images while he was serving as CFO, IC4IC, Zoran Corporation, where he was actively involved in their IPO, and Kulicke & Soffa Inc., where he served for over 20 years. Mr. Kraft holds a B.A. in public accounting from Haifa University and an MBA from Stanford University.